Targeted disruption of nemo-like kinase inhibits tumor cell growth by simultaneous suppression of cyclin D1 and CDK2 in human hepatocellular carcinoma

Journal of Cellular Biochemistry

Volumn 110, Issue 3, 2010, Pages 687-696

  Jung, Kwang Hwa ^a   Kim, Jeong Kyu ^a   Noh, Ji Heon ^a   Eun, Jung Woo ^a   Bae, Hyun Jin ^a   Xie, Hong Jian ^a   Ahn, Young Min ^b   Park, Won Sang ^a   Lee, Jung Young ^a   Nam, Suk Woo ^a  

^a The Catholic University of Korea   (South Korea)

^b Kyung Hee University   (South Korea)

Author keywords

CDK2; Cell cycle arrest; Cyclin D1; Hepatocellular carcinoma; NLK

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE 2; NEMO LIKE KINASE; PHOSPHOTRANSFERASE; UNCLASSIFIED DRUG;

ARTICLE; CANCER GROWTH; CELL CYCLE ARREST; CLINICAL ARTICLE; CONTROLLED STUDY; GENE OVEREXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INHIBITION KINETICS; LIVER CELL CARCINOMA; MITOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; UPREGULATION;

APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL CYCLE; CELL PROLIFERATION; CYCLIN D1; CYCLIN-DEPENDENT KINASE 2; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE SILENCING; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR TFIIIA;

EID: 77952729756     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22579     Document Type: Article

References (31)

1. Bienz M, Clevers H. 2000. Linking colorectal cancer to Wnt signaling. Cell 103:311-320.
2. Bruix J, Boix L, Sala M, Llovet JM. 2004. Focus on hepatocellular carcinoma. Cancer Cell 5:215-219.
3. Choi KW, Benzer S. 1994. Rotation of photoreceptor clusters in the developing Drosophila eye requires the nemo gene. Cell 78:125-136. (Pubitemid 24228307)
4. de La Coste A, Romagnolo B, Billuart P, Renard CA, Buendia MA, Soubrane O, Fabre M, Chelly J, Beldjord C, Kahn A, Perret C. 1998. Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc Natl Acad Sci USA 95:8847-8851.
5. Fearnhead NS, Britton MP, Bodmer WF. 2001. The ABC of APC. Hum Mol Genet 10:721-733.
6. Grana X, Reddy EP. 1995. Cell cycle control in mammalian cells: Role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs). Oncogene 11:211-219.
7. Ishitani T, Ninomiya-Tsuji J, Nagai S, Nishita M, Meneghini M, Barker N, Waterman M, Bowerman B, Clevers H, Shibuya H, Matsumoto K. 1999. The TAK1-NLK-MAPK-related pathway antagonizes signalling between beta-catenin and transcription factor TCF. Nature 399:798-802.
8. Ishitani T, Kishida S, Hyodo-Miura J, Ueno N, Yasuda J, Waterman M, Shibuya H, Moon RT, Ninomiya-Tsuji J, Matsumoto K. 2003a. The TAK1-NLK mitogen-activated protein kinase cascade functions in the Wnt-5a/Ca(2+) pathway to antagonize Wnt/beta-catenin signaling. Mol Cell Biol 23:131-139.
9. Ishitani T, Ninomiya-Tsuji J, Matsumoto K. 2003b. Regulation of lymphoid enhancer factor 1/T-cell factor by mitogen-activated protein kinase-related Nemo-like kinase-dependent phosphorylation in Wnt/beta-catenin signaling. Mol Cell Biol 23:1379-1389.
10. Kaletta T, Schnabel H, Schnabel R. 1997. Binary specification of the embryonic lineage in Caenorhabditis elegans. Nature 390:294-298.
11. Kanei-Ishii C, Ninomiya-Tsuji J, Tanikawa J, Nomura T, Ishitani T, Kishida S, Kokura K, Kurahashi T, Ichikawa-Iwata E, Kim Y, Matsumoto K, Ishii S. 2004. Wnt-1 signal induces phosphorylation and degradation of c-Myb protein via TAK1, HIPK2, and NLK. Genes Dev 18:816-829.
12. Katoh M. 2005. WNT/PCP signaling pathway and human cancer (review). Oncol Rep 14:1583-1588.
13. Liu J, Stevens J, Rote CA, Yost HJ, Hu Y, Neufeld KL, White RL, Matsunami N. 2001. Siah-1 mediates a novel beta-catenin degradation pathway linking p53 to the adenomatous polyposis coli protein. Mol Cell 7:927-936.
14. Meneghini MD, Ishitani T, Carter JC, Hisamoto N, Ninomiya-Tsuji J, Thorpe CJ, Hamill DR, Matsumoto K, Bowerman B. 1999. MAP kinase and Wnt pathways converge to downregulate an HMG-domain repressor in Caenorhabditis elegans. Nature 399:793-797.
15. Naishiro Y, Yamada T, Takaoka AS, Hayashi R, Hasegawa F, Imai K, Hirohashi S. 2001. Restoration of epithelial cell polarity in a colorectal cancer cell line by suppression of beta-catenin/T-cell factor 4-mediated gene transactivation. Cancer Res 61:2751-2758.
16. Nam SW, Park JY, Ramasamy A, Shevade S, Islam A, Long PM, Park CK, Park SE, Kim SY, Lee SH, Park WS, Yoo NJ, Liu ET, Miller LD, Lee JY. 2005. Molecular changes from dysplastic nodule to hepatocellular carcinoma through gene expression profiling. Hepatology 42:809-818.
17. Pang A, Ng IO, Fan ST, Kwong YL. 2003. Clinicopathologic significance of genetic alterations in hepatocellular carcinoma. Cancer Genet Cytogenet 146:8-15.
18. Peifer M, Polakis P. 2000. Wnt signaling in oncogenesis and embryogenesis - A look outside the nucleus. Science 287:1606-1609.
19. Polakis P. 1999. The oncogenic activation of beta-catenin. Curr Opin Genet Dev 9:15-21.
20. Satoh S, Daigo Y, Furukawa Y, Kato T, Miwa N, Nishiwaki T, Kawasoe T, Ishiguro H, Fujita M, Tokino T, Sasaki Y, Imaoka S, Murata M, Shimano T, Yamaoka Y, Nakamura Y. 2000. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Nat Genet 24:245-250.
21. Shin TH, Yasuda J, Rocheleau CE, Lin R, Soto M, Bei Y, Davis RJ, Mello CC. 1999. MOM-4, a MAP kinase kinase kinase-related protein, activates WRM-1/LIT-1 kinase to transduce anterior/posterior polarity signals in C. elegans. Mol Cell 4:275-280.
22. Smit L, Baas A, Kuipers J, Korswagen H, van de Wetering M, Clevers H. 2004. Wnt activates the Tak1/Nemo-like kinase pathway. J Biol Chem 279:17232-17240.
23. Soto Martinez JL, Cabrera Morales CM, Serrano Ortega S, Lopez-Nevot MA. 2005. Mutation and homozygous deletion analyses of genes that control the G1/S transition of the cell cycle in skin melanoma: p53, p21, p16 and p15. Clin Transl Oncol 7:156-164.
24. Thorgeirsson SS, Grisham JW. 2002. Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet 31:339-346. (Pubitemid 35154440)
25. Thorpe CJ, Moon RT. 2004. Nemo-like kinase is an essential co-activator of Wnt signaling during early zebrafish development. Development 131:2899-2909.
26. Topol L, Jiang X, Choi H, Garrett-Beal L, Carolan PJ, Yang Y. 2003. Wnt-5a inhibits the canonical Wnt pathway by promoting GSK-3-independent beta-catenin degradation. J Cell Biol 162:899-908. (Pubitemid 37087729)
27. van de Wetering M, Sancho E, Verweij C, de Lau W, Oving I, Hurlstone A, van der Horn K, Batlle E, Coudreuse D, Haramis AP, Tjon-Pon-Fong M, Moerer P, van den Born M, Soete G, Pals S, Eilers M, Medema R, Clevers H. 2002. The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 111:241-250.
28. Verheyen EM, Mirkovic I, MacLean SJ, Langmann C, Andrews BC, MacKinnon C. 2001. The tissue polarity gene nemo carries out multiple roles in patterning during Drosophila development. Mech Dev 101:119-132. (Pubitemid 32186316)
29. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D. 1993. p21 is a universal inhibitor of cyclin kinases. Nature 366:701-704. (Pubitemid 24036020)
30. Yasuda J, Tsuchiya A, Yamada T, Sakamoto M, Sekiya T, Hirohashi S. 2003. Nemo-like kinase induces apoptosis in DLD-1 human colon cancer cells. Biochem Biophys Res Commun 308:227-233. (Pubitemid 36937170)
31. Zeng W, Wharton KA, Jr., Mack JA, Wang K, Gadbaw M, Suyama K, Klein PS, Scott MP. 2000. Naked cuticle encodes an inducible antagonist of Wnt signalling. Nature 403:789-795. (Pubitemid 30111842)